Informations sur le produit
JBSNF-000088 is a novel analog of insulin that has been shown to have an insulin-sensitizing effect in animal studies. It binds to the insulin receptor, which leads to increased insulin sensitivity. JBSNF-000088 does not bind to the insulin receptor in cancer cells and thus does not promote tumor growth. This drug also has a beneficial metabolic effect on dyslipidemia and enhances mitochondrial function.